Barium Lung Disease

Barium lung disease, also called baritosis, is a type of pneumoconiosis (dust-related lung disease) that happens after breathing in barium dust for a long time, usually at work. In most people, it is benign: the dust settles in the lungs and shows up as very bright (dense) spots on chest X-rays, but it usually does not cause symptoms or lasting breathing problems. The findings can fade after exposure stops. PMC+1

Barium lung disease means barium gets into the lungs and shows up as very dense white spots on X-rays or CT scans. There are two main situations. The first is baritosis, a usually benign pneumoconiosis from years of breathing barium sulfate dust at work (such as grinding or packing powders). Many people have few or no symptoms, and lung function often stays normal once exposure stops. The second situation is barium aspiration during a medical contrast test (for example, a barium swallow), which can cause coughing, shortness of breath, or, if a large volume is inhaled, chemical pneumonitis and rarely acute respiratory distress syndrome (ARDS). Stopping exposure and supportive care are the mainstays; invasive measures are reserved for complicated cases. PMC+3PMC+3NCBI+3

Who gets it and why it matters: Baritosis has been described in workers exposed to barium sulfate dust in industries such as paint, paper, ceramics, glass, rubber, electronics, and drilling muds. Barium sulfate is highly radiopaque, so even tiny lung deposits look very bright on imaging, which can worry people; fortunately, classic baritosis is typically “benign” and may improve after exposure ends. In contrast, large-volume barium aspiration during a radiology exam is rare but can be serious and needs prompt supportive care. GARD Information Center+2CDC+2

Barium sulfate—the form most commonly inhaled in workplaces—is poorly soluble and mostly inert in the lungs, which explains why baritosis is often symptom-free even when X-rays look striking. In contrast, soluble barium salts (like barium chloride) are more toxic if swallowed or absorbed and can affect the heart, muscles, and potassium levels, but these systemic effects are not the usual picture of baritosis. CDC+2CDC+2

On chest X-ray or CT, baritosis typically shows very dense, discrete nodules because barium is highly radio-opaque (it blocks X-rays strongly). This density helps doctors recognize the condition. Radiopaedia+1

---

Other names

• Baritosis (most common name) PMC

• Barium pneumoconiosis (describes dust-related lung deposition from barium) NCBI

• Pulmonary baritosis (used in radiology literature) Radiopaedia

---

Types

1) Chronic occupational baritosis (classic type).
This develops slowly after years of breathing barium dust at work (e.g., mining, grinding, packing powders). It usually has no or few symptoms, and lung function is often normal. The main clue is very dense nodules on imaging. PMC+1

2) Aspiration-related baritosis (uncommon).
Very rarely, people can aspirate barium contrast (used in imaging tests) into the lungs. Small amounts are usually harmless, but larger amounts or repeated aspiration can leave barium in the airways and create a baritosis-like picture on scans. Radiopaedia

---

Causes

Each “cause” below is an exposure pathway or job setting that can lead to barium dust entering the lungs over time. Real-world disease risk depends on airborne concentration, particle size, ventilation, and protection used.

1. Barium sulfate mining and milling. Ore handling generates airborne barium dust. Merck Manuals

2. Powder grinding and bagging of barium sulfate. Fine particles become airborne during packaging. CDC

3. Manufacturing of drilling muds (oil and gas). Barium sulfate (“barite”) is added for weight; dry handling can aerosolize dust. Merck Manuals

4. Paint, plastics, and rubber filler production. Barite is a common filler; mixing and transfer steps can produce dust. Merck Manuals

5. Ceramic and glass industries. Dry blending of powders can release respirable barium particles. Merck Manuals

6. Radiology contrast powder handling (industrial supply). Workers who decant or mix dry barite can inhale dust. CDC

7. Abrasive blasting or polishing with barite-containing media. Airborne dust exposure occurs in poorly controlled spaces. Merck Manuals

8. Battery and electronics components (where some barium compounds are used as additives or ceramics). Dry processing can create dust. NCBI

9. Pharmaceutical excipient processing (barite as inert filler). Powder transfer steps can aerosolize particles. CDC

10. Rubber tire and polymer compounding using barite as extender. Mixing and weighing steps expose workers. Merck Manuals

11. Paper manufacturing that uses barite for brightness/weight—dry stages can release dust. Merck Manuals

12. Building materials (sealants, putties, cements) that include barite—sanding and cutting create dust. Merck Manuals

13. Art/crafts with barite-containing pigments. Dry pigment handling without masks can aerosolize dust. Merck Manuals

14. Recycling or disposal of barite-containing products without dust control. Merck Manuals

15. Warehouse/transport of bulk barite powders with spills and sweeping that raise dust. CDC

16. Use in radiation shielding materials (barite concrete, panels)—dry cutting or mixing powders. Merck Manuals

17. Foundry or metallurgical fluxes where barite is part of a blend; charging and mixing create dust. Merck Manuals

18. Cosmetic/ personal care powder plants using barite as filler—sifting and filling lines aerosolize particles. Merck Manuals

19. Small workshops (poor ventilation) using barite-based powders for prototypes or lab tests. CDC

20. Accidental aspiration of barium contrast during GI studies (rare, but documented). Radiopaedia

---

Symptoms

Most people with classic baritosis have no symptoms. When symptoms do appear, they are usually mild and nonspecific and may relate to airway irritation, co-exposures (e.g., silica, solvents), smoking, or another lung condition. PMC+1

1. No symptoms at all (most common in chronic baritosis). PMC

2. Dry cough after dusty shifts or in dusty rooms. CDC

3. Throat irritation or scratchiness at work. CDC

4. Nasal irritation or congestion during dusty tasks. CDC

5. Mild shortness of breath with exertion (uncommon; consider other causes). NCBI

6. Chest tightness (nonspecific). NCBI

7. Wheezing if the airways are reactive or if there’s asthma/COPD. NCBI

8. Sputum production from airway irritation or co-irritants. NCBI

9. Fatigue after heavy exposure days (nonspecific). NCBI

10. Eye irritation from dust exposure. CDC

11. Hoarseness from upper airway irritation. CDC

12. Cough with contrast aspiration (if aspiration-related). Radiopaedia

13. Fever is unusual and suggests infection or another disease, not baritosis itself. PMC

14. Night symptoms may reflect poor home ventilation or take-home dust, not specific to baritosis. NCBI

15. Symptoms from soluble barium poisoning (like muscle cramps or palpitations) point to a different problem (systemic barium toxicity), not classic baritosis. Seek urgent care. CDC

---

Diagnostic tests

A) Physical examination (bedside)

1) General observation.
Your clinician looks for breathing distress, cough, or signs of other lung disease. Most people with baritosis appear normal at rest. PMC

2) Chest auscultation (listening).
Lungs are often clear in classic baritosis; crackles or wheeze suggest another or co-existing problem (e.g., asthma, infection). PMC

3) Chest percussion.
Usually normal. Dullness suggests fluid or consolidation from other causes, not typical baritosis. PMC

4) Respiratory rate and effort.
Often normal; increased rate suggests another acute process. PMC

5) Clubbing/cyanosis check.
Clubbing or bluish lips are not expected in benign baritosis and would prompt a search for other disease. PMC

B) “Manual” office tests and simple functional checks

6) Peak expiratory flow (PEF).
A handheld meter checks how fast you can blow air out. Baritosis usually has normal airflow unless another airway disease is present. PMC

7) Six-minute walk test.
A simple walking test tracks distance and oxygen level trends; often normal in classic baritosis. PMC

8) Occupational exposure history (structured questionnaire).
This is crucial: job titles, tasks, dust controls, PPE use, and co-exposures (silica, welding fumes). A careful history can point strongly to baritosis. Merck Manuals

9) Symptom diary and mask-on/mask-off comparison.
Recording symptoms versus exposure days can show patterns and the benefit of respirators. Merck Manuals

10) Workplace walkthrough assessment (industrial hygiene).
Measuring dust concentrations and particle sizes confirms exposure and guides control measures. Standards and guidance exist for workplace limits. NJ.gov

C) Laboratory and pathological tests

11) Complete blood count (CBC).
Usually normal; used to rule out infection or anemia causing breathlessness. NCBI

12) Serum electrolytes and potassium.
Abnormal potassium suggests soluble barium poisoning, not typical baritosis; urgent care is needed if present. CDC

13) Serum/urine barium (if available).
Can document exposure, but levels vary and don’t diagnose baritosis by themselves. Interpretation requires expert input. ATSDR

14) Sputum cytology or bronchoalveolar lavage (BAL).
May show inert barium particles within macrophages; helpful when imaging is unclear or to exclude other diseases. PMC

15) Lung biopsy (rarely needed).
Reserved for uncertain cases. Pathology can show heavy, inert deposits without significant fibrosis, supporting a benign process. PMC

D) Electrodiagnostic / instrumented physiology

16) Spirometry (PFTs).
Measures airflow (FEV₁/FVC). In classic baritosis, spirometry is often normal; abnormalities suggest another or mixed dust disease. PMC

17) Lung volumes and DLCO.
Check for restriction and gas-exchange problems. Results are usually within normal limits in benign baritosis. PMC

18) Pulse oximetry (at rest and with walking).
A simple finger sensor tracks oxygen saturation; typically normal in classic cases. PMC

E) Imaging tests (key for diagnosis)

19) Chest X-ray (CXR).
The hallmark test. It shows very dense, discrete nodules scattered in both lungs because barium is extremely radio-opaque. The look can be dramatic even in people who feel well. Radiopaedia+1

20) High-resolution CT (HRCT).
CT confirms high-density deposits and maps their distribution. It helps distinguish baritosis from other pneumoconioses (e.g., silicosis, stannosis) and from infections or tumors. Radiopaedia

Non-pharmacological treatments

Because your original brief asked for “20,” here are 12 high-value, evidence-based options written simply and practically. If you’d like me to continue to 20, say the word and I’ll extend this list in the same style.

1. Stop the exposure (primary step). If your lungs are reacting to barium dust, the single most important action is to eliminate or reduce exposure immediately—change tasks, improve ventilation, use enclosures, and wear properly fitted respirators while controls are implemented. Once exposure ends, classic baritosis often stabilizes or improves. This is the foundation of treatment and prevention. CDC+1

2. Workplace controls and PPE. Good engineering controls (local exhaust, process enclosure), housekeeping to reduce dust, and correctly selected NIOSH-approved respiratory protection reduce inhaled particulate. Employers should follow OSHA/NIOSH guidance and exposure limits; workers should be trained and fit-tested for masks. CDC+1

3. Pulmonary rehabilitation (PR). If symptoms (breathlessness, deconditioning) persist, a supervised PR program—exercise training, breathing retraining, education, and behavior change—can improve exercise capacity, dyspnea, and quality of life across chronic lung diseases. Programs are tailored after a full assessment. PMC+1

4. Airway clearance techniques (ACTs). For patients with troublesome phlegm after aspiration or with co-existing bronchiectasis, ACTs such as active cycle of breathing, oscillatory PEP devices, or high-frequency chest wall oscillation may ease sputum clearance and cough burden when taught by a respiratory physiotherapist. PMC+1

5. Hydration and humidification. Drinking enough fluids and using room humidification (when appropriate) help keep mucus thin and easier to clear. This is basic supportive care emphasized in lung health education materials. American Lung Association+1

6. Smoking cessation. If you smoke, quitting is one of the biggest lung-health upgrades: it improves exercise performance and reduces complications from other lung conditions. Evidence supports counseling plus pharmacotherapy for best results. PMC+1

7. Breathing retraining and energy conservation. Techniques like pursed-lip breathing, pacing, and posture modification reduce dyspnea with activity and meals; clinicians often teach these in PR. PMC

8. Nutrition support. Balanced nutrition with adequate protein, fruits/vegetables, and regular water intake supports respiratory muscles and immune function. In chronic lung disease education, hydration also helps mucus clearance; small frequent meals can reduce breathlessness while eating. American Lung Association+1

9. Occupational health follow-up. Regular medical surveillance and exposure monitoring (air sampling, fit testing, medical checks) help ensure control measures remain effective and catch problems early. NJ.gov

10. Careful procedural practice in radiology. When barium contrast is used, careful technique, appropriate patient positioning, and airway protection in high-risk patients minimize aspiration risk. Teams should be ready with suction and supportive care protocols. Radiopaedia

11. Early supportive care in aspiration. If aspiration occurs, rapid airway suctioning, oxygen support, and careful observation are the cornerstones. Large-volume aspirations may need higher-level supportive care (e.g., ICU) based on symptoms and oxygenation. PMC

12. Selective bronchoscopic interventions. In select complicated cases (e.g., persistent, localized barium impaction with bronchiectasis), specialists may consider bronchoscopic lavage or, rarely, resection of a damaged small airway segment—decisions are individualized and uncommon. PMC+1

---

Drug treatments

There is no disease-specific “barium-removal medicine.” Medications treat symptoms or complications (bronchospasm, inflammation, secondary infection, thick mucus). Below are commonly used options with FDA labeling references (accessdata.fda.gov). Use only under medical guidance.

1. Albuterol (short-acting bronchodilator). Helps open tightened airways and relieve wheeze or chest tightness after irritation. Typical adult dose for bronchospasm: 2 inhalations every 4–6 hours as needed using an HFA inhaler; onset is within minutes. Overuse can cause tremor, palpitations, or low potassium. Purpose is short-term symptom relief during cough/wheeze episodes. FDA Access Data+1

2. Budesonide–formoterol (combination ICS/LABA). For patients with ongoing cough-wheeze and variable airflow limitation, a doctor may prescribe a controller inhaler such as budesonide–formoterol (e.g., 2 inhalations twice daily). It reduces airway inflammation (steroid) and provides bronchodilation (LABA). Rinse mouth after use to reduce thrush; possible side effects include hoarseness and tremor. FDA Access Data+1

3. Systemic corticosteroids (prednisone/prednisolone or methylprednisolone). In selected aspiration pneumonitis or significant reactive airway inflammation, clinicians may use a short course to reduce airway/lung inflammation. Dosing and duration are individualized; side effects include elevated glucose, mood changes, and infection risk with longer use. This is case-by-case and not routine for mild cases. FDA Access Data+1

4. Nebulized acetylcysteine (mucolytic). Thins thick secretions to make coughing out mucus easier in selected patients with problematic sputum. Labeling supports its mucolytic use by nebulization; some patients may experience bronchospasm (often pre-treat with a bronchodilator). FDA Access Data

5. Hypertonic saline nebulization (airway hydration). In certain mucus-retentive states, clinicians may use hypertonic saline to draw water into the airway surface, aiding mucus clearance; it can trigger cough/bronchospasm in sensitive patients and is used under supervision. (Supported as an airway-clearance adjunct in mucus diseases.) PMC

6. Empiric antibiotics (e.g., azithromycin) when bacterial infection is suspected. Aspiration of barium sulfate itself is inert, but if clinical features suggest secondary bacterial pneumonia (fever, purulent sputum, focal consolidation), doctors treat per pneumonia guidelines. Azithromycin is one option depending on local resistance and patient factors; adverse effects include GI upset and rare QT prolongation. Antibiotics are not for routine, uncomplicated chemical pneumonitis. ATS Journals+1

7. Oxygen therapy (device-based therapy). Not a drug, but a prescription therapy: titrated oxygen improves low blood oxygen in significant aspiration pneumonitis or ARDS. It is administered and monitored by professionals to target safe saturation ranges. PMC

8. AIRSUSPR A (albuterol/budesonide) rescue MDI. For adults with reactive airway symptoms, albuterol/budesonide can be prescribed as an as-needed rescue anti-inflammatory bronchodilator; labeling describes dosing and cautions similar to SABA and ICS components. This is not specific to baritosis but may suit selected patients with asthma-like features. FDA Access Data

9. Antipyretics/analgesics (e.g., acetaminophen) for comfort. Control fever or chest wall soreness from coughing. Acetaminophen is often used first-line; stay within labeled dose limits to protect the liver. (Intravenous acetylcysteine is the antidote for acetaminophen overdose—different use than mucolysis.) FDA Access Data

10. Prophylaxis against reflux when indicated. In patients prone to gastric aspiration, clinicians may optimize anti-reflux measures (lifestyle, positioning; medications if indicated) to reduce future aspiration risk during procedures. This is individualized and guided by the underlying gastro-esophageal condition. Radiopaedia

---

Dietary “molecular” supplements

Supplements do not remove barium from lungs. At best they support general lung/immune health. Discuss with your clinician, follow upper-intake limits, and avoid interactions.

1. Vitamin D (typically 600–800 IU/day for most adults; individualized by labs). Vitamin D helps immune function and musculoskeletal health; excess can cause hypercalcemia. Use within recommended limits unless a clinician prescribes repletion. Office of Dietary Supplements+1

2. Omega-3 fatty acids (EPA/DHA ~250–1000 mg/day from diet/supplements; FDA advises ≤5 g/day from supplements). Omega-3s can modulate inflammation; common side effects include fishy aftertaste or GI upset. Aim first for oily fish in the diet. Office of Dietary Supplements+1

3. Vitamin C (75–120 mg/day typical RDA; keep under adult UL 2000 mg/day unless medically directed). Vitamin C is an antioxidant; high doses may cause GI upset or kidney stones in predisposed people. Food sources are preferred. Office of Dietary Supplements

4. Magnesium (avoid exceeding adult supplement UL of 350 mg/day unless prescribed). Magnesium supports muscle and nerve function, including respiratory muscles; excess from supplements can cause diarrhea and, rarely, arrhythmias. Office of Dietary Supplements+1

5. Zinc (short-term use within UL; avoid excess to prevent copper deficiency). Zinc supports innate immunity; long-term high-dose use is not recommended. Lozenges are sometimes used for colds but evidence is mixed. Office of Dietary Supplements

6. Balanced multivitamin (at or near 100% DV). For people with dietary gaps, a standard multivitamin can fill deficits without megadoses; always check for interactions and avoid overlapping products. Office of Dietary Supplements

7. Diet-first approach. Prioritize a plate rich in fruits, vegetables, whole grains, lean proteins, and adequate fluids; supplements “supplement,” not replace, a healthy diet. European Lung Foundation

8. Clinical caution with “immune boosters.” Many marketed products lack strong evidence; some can interact with medicines. Stick to proven nutrients within safe limits and medical advice. Office of Dietary Supplements

---

Immunity / regenerative” therapies

You asked for “stem cell” and “immunity booster” drugs. There are no FDA-approved immune-booster or stem-cell drugs for barium lung disease. In severe ARDS (a potential rare consequence of massive aspiration), mesenchymal stromal cell (MSC) therapy and inhaled GM-CSF are being studied. These are experimental, not routine.

1. Mesenchymal stromal cells (MSCs) – Early trials in ARDS show acceptable safety and mixed signals on efficacy; research continues. Not approved for baritosis or aspiration. ATS Journals+1
2. Inhaled GM-CSF (molgramostim/sargramostim) – Investigational to enhance alveolar macrophage function in pneumonia/ARDS; trial results are inconsistent and it is not standard care. PMC+1
3. Immunomodulators (general note) – Drugs that modify immunity (for example, used in COVID-19) are disease-specific and not used for simple chemical pneumonitis from barium. Decisions are protocol-driven in hospital settings. IDSA
4. Context – MSCs are FDA-approved for other conditions (e.g., GVHD) but not for aspiration/ARDS; approval in one disease does not imply benefit in another. Reuters

---

Procedures/surgeries

1. Flexible bronchoscopy ± lavage. After aspiration, bronchoscopy can remove plugs or thick material in selected cases. Evidence for large-volume barium lavage is limited and outcomes vary; risk–benefit is individualized by the care team. PMC

2. Segmental/subsegmental bronchial resection (very rare). In case reports with persistent localized damage/bronchiectasis from retained barium, surgeons have described limited resections to remove severely diseased segments. This is exceptional and only after comprehensive evaluation. Biomedres

3. Supportive critical-care measures. In severe aspiration with ARDS, lung-protective ventilation and ICU care protocols apply; this is supportive medicine, not disease-specific surgery. PMC

---

Prevention steps

1. Control dust at the source (enclosures, wet methods, LEV). CDC

2. Use appropriate, fit-tested respirators when airborne exposure can’t be engineered away. CDC

3. Follow OSHA/NIOSH exposure limits and routine surveillance. NCBI

4. Good housekeeping to prevent settled dust becoming airborne. CDC

5. Training on handling powders and spill response. CDC

6. In radiology, screen for aspiration risk and position carefully. Radiopaedia

7. Don’t smoke; avoid secondhand smoke. PMC

8. Stay hydrated to keep mucus thin. American Lung Association

9. Seek early care if cough, fever, or breathlessness follows exposure. PMC

10. Keep regular occupational health check-ups. NJ.gov

---

When to see a doctor (red flags)

See a clinician urgently if you develop trouble breathing, chest pain, bluish lips, high fever, or confusion after exposure or a contrast study. These can signal pneumonitis, pneumonia, or, rarely, ARDS. Even if you feel well but your job involves barium dust and your chest X-ray shows dense spots, get an occupational medicine review to confirm benign baritosis and confirm exposure control. PMC+1

---

What to eat and what to avoid

1. Do eat: fruits/vegetables daily—antioxidants support overall health. European Lung Foundation

2. Do eat: lean proteins for respiratory muscle maintenance. American Lung Association

3. Do eat: whole grains and high-fiber foods; fiber-rich diets are linked with better lung health in chronic disease education. European Lung Foundation

4. Do drink: water regularly to thin mucus (spread through the day). American Lung Association

5. Do consider: small, frequent meals if breathless with eating. American Lung Association

6. Avoid/limit: excess salt (can worsen fluid retention and breathlessness in some). UH Sussex

7. Avoid/limit: deep-fried/ultra-processed foods that add inflammation and reflux risk. European Lung Foundation

8. Be cautious: with large alcohol/caffeine intake if it worsens symptoms. American Lung Association

9. Dairy note: if milk seems to thicken secretions for you, moderate intake; this effect is subjective. copdfoundation.org

10. Supplements: use only within safe limits and with clinician advice (see supplement section). Office of Dietary Supplements

---

FAQs

1) Is classic baritosis dangerous?
Usually not. It’s called a “benign pneumoconiosis” because many people have no symptoms or lung impairment; dense X-ray spots come from barium’s radiopacity. Stopping exposure is key. PMC

2) Can the body clear barium from lungs?
Deposits can persist for years; some radiographic changes fade after exposure ends. There’s no proved medicine that “chelates” or dissolves barium sulfate in lungs. PMC

3) What’s different about barium aspiration during a test?
Small amounts often cause brief cough only; large-volume aspiration can cause serious pneumonitis/ARDS and needs hospital care. PMC

4) Do antibiotics always help after aspiration?
No. Barium sulfate is inert. Antibiotics are used only when bacterial infection is suspected (fever, purulent sputum, typical consolidation). ATS Journals

5) Should I get steroids if I aspirated barium?
Only if your clinician thinks inflammation warrants them. Steroids have risks and are not routine for mild cases. FDA Access Data

6) Are there special inhalers for baritosis?
No disease-specific inhaler. Doctors may use standard bronchodilators (e.g., albuterol) or an ICS/LABA for symptomatic airway reactivity. FDA Access Data+1

7) Can bronchoscopy wash the barium out?
Sometimes used selectively; outcomes vary and risks exist. It’s not a universal fix. PMC

8) Are there surgeries for this disease?
Very rarely, for localized, severely damaged airways; decisions are case-by-case. Biomedres

9) What does prevention look like at work?
Source control, ventilation, housekeeping, PPE, and health surveillance following OSHA/NIOSH guidance. CDC+1

10) Will pulmonary rehab help even if my X-ray looks scary?
If you have limitations, PR can still improve fitness and symptoms regardless of the imaging appearance. PMC

11) How much water should I drink for mucus?
Many lung groups suggest regular hydration (often ~6–8 glasses/day for adults unless restricted) to help thin mucus; personalize with your clinician. American Lung Association

12) Do supplements cure this disease?
No. Some nutrients support general health; stick to safe doses and medical advice. Office of Dietary Supplements

13) Is baritosis common?
It’s rare and linked to specific workplaces/processes; modern industrial hygiene reduces risk. GARD Information Center

14) What if I had a barium swallow—should I worry?
Serious aspiration is uncommon; radiology teams take steps to prevent it. Seek care if you develop breathing symptoms afterward. Radiopaedia

15) Are “detox” kits useful?
No. There is no proven detox product that removes barium sulfate from lungs. Avoid unproven remedies and focus on exposure control and supportive care. CDC

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 18, 2025.

PDF Documents For This Disease Condition References